Manjunatha M Ramaiah

Title: Manjunatha M Ramaiah: Innovator in Anticancer Research

Introduction

Manjunatha M Ramaiah is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. With a total of 2 patents to his name, Ramaiah is recognized for his innovative approach to drug discovery.

Latest Patents

Ramaiah's latest patents include the development of tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors. The present disclosure describes heterocyclic compounds of Formula I or its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms, and pharmaceutically active derivatives thereof. These compounds have been characterized to exhibit high anticancer activity. They are useful as medicaments and can be employed in the manufacture of medicaments for the treatment, prevention, or suppression of diseases and conditions mediated by one or more BET family of bromodomains.

Career Highlights

Manjunatha M Ramaiah is currently associated with Jubilant Biosys Limited, where he continues to advance his research in medicinal chemistry. His work focuses on synthesizing and characterizing novel compounds that can lead to effective treatments for various diseases.

Collaborations

Ramaiah has collaborated with notable colleagues, including Saravanan Vadivelu and Sridharan Rajagopal, to further enhance the scope and impact of his research.

Conclusion

Manjunatha M Ramaiah is a dedicated inventor whose work in the field of anticancer research is paving the way for new therapeutic options. His innovative contributions and collaborations highlight the importance of teamwork in scientific advancements.